These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21215477)

  • 21. Comparison of insulin resistance and serum high-sensitivity C-reactive protein levels according to the fasting blood glucose subgroups divided by the newly recommended criteria for fasting hyperglycemia in 10059 healthy Koreans.
    Rhee EJ; Kim YC; Lee WY; Jung CH; Sung KC; Ryu SH; Oh KW; Kim SW
    Metabolism; 2006 Feb; 55(2):183-7. PubMed ID: 16423624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interpretation of serum C-reactive protein (CRP) levels for cardiovascular disease risk is complicated by race, pulmonary disease, body mass index, gender, and osteoarthritis.
    Kraus VB; Stabler TV; Luta G; Renner JB; Dragomir AD; Jordan JM
    Osteoarthritis Cartilage; 2007 Aug; 15(8):966-71. PubMed ID: 17395501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of plasma high-sensitivity C-reactive protein levels in Japanese patients with stable coronary artery disease: the Japan NCVC-Collaborative Inflammation Cohort (JNIC) Study.
    Momiyama Y; Kawaguchi A; Kajiwara I; Ohmori R; Okada K; Saito I; Konishi M; Nakamura M; Sato S; Kokubo Y; Mannami T; Adachi H; Kario K; Iso H; Ohsuzu F; Tsushima M
    Atherosclerosis; 2009 Nov; 207(1):272-6. PubMed ID: 19439303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relations between fasting serum lipids and high-sensitivity C-reactive protein level in Chengdu residents].
    Shu Y; He S; Chen XP; Lü ZB; Yang R; Liu K; Cui KJ; Huang DJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Feb; 40(2):125-30. PubMed ID: 22490712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-grade inflammation is a risk factor for clinical stroke events in addition to silent cerebral infarcts in Japanese older hypertensives: the Jichi Medical School ABPM Study, wave 1.
    Ishikawa J; Tamura Y; Hoshide S; Eguchi K; Ishikawa S; Shimada K; Kario K
    Stroke; 2007 Mar; 38(3):911-7. PubMed ID: 17272770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An association between body mass index and high-sensitivity C-reactive protein concentrations is influenced by age in community-dwelling persons.
    Kawamoto R; Kusunoki T; Abe M; Kohara K; Miki T
    Ann Clin Biochem; 2013 Sep; 50(Pt 5):457-64. PubMed ID: 23880621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER Study.
    Glynn RJ; MacFadyen JG; Ridker PM
    Clin Chem; 2009 Feb; 55(2):305-12. PubMed ID: 19095726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relations of plasma high-sensitivity C-reactive protein to various cardiovascular risk factors.
    Ryu SY; Lee YS; Park J; Kang MG; Kim KS
    J Korean Med Sci; 2005 Jun; 20(3):379-83. PubMed ID: 15953856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-sensitivity C-reactive protein affects central haemodynamics and augmentation index in apparently healthy persons.
    Kampus P; Kals J; Ristimäe T; Fischer K; Zilmer M; Teesalu R
    J Hypertens; 2004 Jun; 22(6):1133-9. PubMed ID: 15167448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High sensitivity C-reactive protein associated with different health predictors in middle-aged and oldest old Chinese.
    Zhai Y; Shi XM; Fitzgerald SM; Qian HZ; Kraus VB; Sereny M; Hu P; Yin ZX; Xu JW; Zeng Y
    Biomed Environ Sci; 2012 Jun; 25(3):257-66. PubMed ID: 22840575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
    Ridker PM; Danielson E; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Macfadyen JG; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
    Lancet; 2009 Apr; 373(9670):1175-82. PubMed ID: 19329177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of oxidative DNA damage and C-reactive protein in women at risk for cardiovascular disease.
    Noren Hooten N; Ejiogu N; Zonderman AB; Evans MK
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2776-84. PubMed ID: 22982460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of visceral adiposity and exercise participation with C-reactive protein, insulin resistance, and endothelial dysfunction in Korean healthy adults.
    Kim K; Valentine RJ; Shin Y; Gong K
    Metabolism; 2008 Sep; 57(9):1181-9. PubMed ID: 18702942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High sensitive C-reactive protein (hsCRP), cardiovascular events and mortality in the aged: a prospective 9-year follow-up study.
    Kuoppamäki M; Salminen M; Vahlberg T; Irjala K; Kivelä SL; Räihä I
    Arch Gerontol Geriatr; 2015; 60(1):112-7. PubMed ID: 25456891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US.
    Cushman M; McClure LA; Howard VJ; Jenny NS; Lakoski SG; Howard G
    Clin Chem; 2009 Sep; 55(9):1627-36. PubMed ID: 19643839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlations between the level of high-sensitivity C-reactive protein and cardiovascular risk factors in Korean adults with cardiovascular disease or diabetes mellitus: the CALLISTO study.
    Seo SM; Baek SH; Jeon HK; Kang SM; Kim DS; Kim WS; Kim HS; Rha SW; Park JS; Seong IW; Ahn YK; Yoon JH; Cha TJ
    J Atheroscler Thromb; 2013; 20(7):616-22. PubMed ID: 23676341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors.
    Olsen MH; Christensen MK; Hansen TW; Gustafsson F; Rasmussen S; Wachtell K; Borch-Johnsen K; Ibsen H; Jørgensen T; Hildebrandt P
    J Hypertens; 2006 Apr; 24(4):655-61. PubMed ID: 16531793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-sensitivity C-reactive protein in the low- and intermediate-Framingham risk score groups: analysis with 18F-fluorodeoxyglucose positron emission tomography.
    Yang SJ; Kim S; Choi HY; Kim TN; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
    Int J Cardiol; 2013 Mar; 163(3):277-281. PubMed ID: 21719129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective follow-up study of the relationship between C-reactive protein and human cancer risk in the Chinese Kailuan Female Cohort.
    Wang G; Li N; Chang S; Bassig BA; Guo L; Ren J; Su K; Li F; Chen S; Wu S; Zou Y; Dai M; Zheng T; He J
    Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):459-65. PubMed ID: 25490990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discordant risk: overweight and cardiometabolic risk in Chinese adults.
    Gordon-Larsen P; Adair LS; Meigs JB; Mayer-Davis E; Herring A; Yan SK; Zhang B; Du S; Popkin BM
    Obesity (Silver Spring); 2013 Jan; 21(1):E166-74. PubMed ID: 23505200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.